TP53 and cancer: NMD inhibition through a combination treatment of NMDI14, which disrupts the UPF1-SMG7 interaction, and a stop codon read-through drug, G418, led to expression of full-length p53 in different cancer cell lines, ultimately leading to cell death (Table 2) [141].